$100 off your first order. Code: WELCOME100

Available in Injection & Nose Spray
Compounded PT-141 Injection
PT-141 is a prescription peptide therapy that supports sexual desire and arousal by acting on specific pathways in the brain. Unlike traditional options that focus on blood flow or hormone levels, PT-141 works centrally to support sexual motivation, responsiveness, and intimacy.
Because it targets the brain’s signaling pathways involved in desire, PT-141 may be explored by both women and men when low libido feels mental, disconnect-based, or unresponsive to other approaches. It does not rely on testosterone or estrogen to work and is considered a non-hormonal option.
The active compound in PT-141 (bremelanotide) is FDA-approved in branded form. Compounded PT-141 is prescribed by licensed medical providers following a medical intake to determine whether it is appropriate for your health history, goals, and individual needs.

4.9/5
PT-141 is a prescription peptide therapy used to support sexual desire and arousal by acting on specific pathways in the brain. Unlike treatments that focus on blood flow or hormone levels, PT-141 works centrally to support sexual motivation, responsiveness, and intimacy. It may be explored when low desire feels mental, emotional, or disconnect-based rather than purely physical.
PT-141 works at the brain level rather than targeting blood flow or physical performance alone. It activates melanocortin receptors involved in sexual desire and arousal, which is why it may be considered when traditional options are ineffective, not well tolerated, or do not address desire itself.
PT-141 for women:
PT-141 may be considered by women experiencing low sexual desire that feels emotional, mental, or disconnect-based. It does not rely on estrogen or testosterone to work and is sometimes explored when other approaches have not been effective.
PT-141 for men:
PT-141 supports sexual desire and arousal rather than focusing solely on physical performance. Men may explore PT-141 when desire is low despite normal hormone levels or when blood-flow-focused options are not a good fit.
A licensed medical provider determines whether PT-141 is appropriate based on individual health history and goals.
The active compound in PT-141, bremelanotide, is FDA-approved in branded form. Compounded PT-141 is prescribed by licensed medical providers under FDA compounding regulations following a medical intake.
PT-141 is available in different delivery forms, including injectable and nasal spray options. During the intake process, patients select their preferred option, which is then reviewed by a licensed provider. The provider determines whether PT-141 and the selected delivery form are appropriate based on medical history and individual needs.
The statements on this page have not been evaluated by the Food and Drug Administration. Compounded medications are not FDA-approved. All treatment decisions are made by a licensed provider based on your individual health profile and medical needs.
* Prices shown reflect the estimated monthly equivalent cost of our quarterly plans with active coupon applied.
All multi-month plans are paid in full at checkout, or with buy now, pay later options. Actual pricing may vary based on the medication and treatment plan prescribed by your provider.
*The FDA does not review or approve compounded medications for safety or effectiveness. Compounded medications are prepared by licensed pharmacies pursuant to a valid prescription.
Changes in sexual desire are common and often influenced by stress, mental load, life transitions, and emotional connection – not just hormones or physical health. For many people, desire doesn’t disappear. It simply feels harder to access.
PT-141 is designed for individuals who feel mentally disconnected from desire or intimacy, even when everything else appears “normal.” This approach focuses on supporting the brain pathways involved in motivation and responsiveness, rather than physical performance alone.
This isn’t about fixing something that’s broken or forcing a response. It’s about supporting desire in a way that feels aligned, personalized, and guided by a licensed medical provider.



*Individual experiences may vary

From a behavioral science perspective, desire is responsive to mental load, emotional well being, and long-term stress. Those signals can change quietly over time, even when someone feels healthy and stable in their life.
PT-141 works through brain pathways involved in desire rather than relying on hormones or circulation alone. For qualified patients, that distinction matters. It allows support to match what’s actually happening instead of forcing a solution that doesn’t fit.
Seeing that shift in patients, from frustration or self-doubt to relief and confidence, is the part that gives me the greatest fulfillment.

Happy Members

Google Review
of Telzen Md customers have left 5 star reviews
Would recommend Telezen to their family and friends
I am coming up on my golden years, and as of 4 years ago, my desire for physical touch by my husband repulsed me. I was desperate to get that desire back. I read to take it 45 min before “the moment” when with me … took 2 hours. It started with the continual need to stretch and vulvar sensitivity. After that, I realized I had finally found a way to regain feeling there. The sensation lasted about 18 hours. Fell asleep fine on it. It did not keep me awake. I will definitely continue using this. It has been a lifesaver.
My husband and I had not had intercourse for over a year, since we had our 3rd child. I took it about two hours before bed, after which I felt slightly hot and nauseous for a few minutes. About an hour later I was feeling the need to stretch, but the stretching felt good. I also started getting turned on, almost like I was 18 again. We not only had sex for the first time in a year, I orgasmed more than I ever have before, and had the best night's sleep. I've now taken it twice more with the same effect. PT-141 has changed my life. I read that men could also take it and it had the same effect.
This medication worked disturbingly well! I nervously took it with the nausea pill and started a relaxation routine right afterwards. I felt minimal nausea and waited anxiously for 2 hours before bed. I could feel the sensation, but it was easily ignored. However, I woke multiple times in the middle of the night with an insatiable urge that has never happened... It was undeniable and could not be ignored. Not only did it make for a fun night, but it continued throughout the next day. I'm so shocked by how well the medicine worked, and will plan carefully now to administer when there's more time to play.
I did not experience any nausea which was mentioned as a possible side effect. However, the instructions suggested taking 45 minutes before activity but it took about 2 hours to kick in, but make no mistake, it worked and is still working… I woke up in the middle of the night severely stimulated and turned on. As I am writing this (11 am next morning) I am still highly stimulated. This really works!!
Step
1
Complete a short online intake and connect with a licensed medical provider through Telezen MD’s secure telehealth platform. Your physician will review your health history and determine whether a personalized treatment plan is appropriate for you.

Step
2
If approved, your prescribed medication is prepared by our partner pharmacy and shipped directly to your home. Delivery is discreet, fast, reliable, and included with your care.

Step
3
Telezen MD provides continued physician oversight, 24/7 access to medical support, and a seamless patient portal experience—along with structured digital education and behavioral support designed to help you stay consistent and achieve results.

Telezen MD works exclusively with US-licensed, quality-audited 503A compounding pharmacies selected through a deliberate review process led by our medical and operations team. We do not partner with mass-production or lowest-cost facilities. Instead, we prioritize sterile environments, documented quality systems, and consistency from batch to batch. We build long-term relationships with our pharmacy partners to ensure treatments remain reliable, personalized, and aligned with long-term patient outcomes. This is how we deliver care with intention, accountability, and a higher standard than transactional telehealth models.













Telezen MD is led by a board-certified medical team dedicated to providing safe, effective, and science-backed treatments. Our U.S.-licensed healthcare providers carefully evaluate each patient and create personalized prescription treatment plans tailored to your unique goals — from vitality and wellness to longevity and aesthetic health.

Comprehensive family medicine, preventative care, and evidence-based treatment across the lifespan.
Education & Training:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Obesity medicine, metabolic health, weight management, and long-term wellness-focused care.
Board Certifications:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Internal medicine, telemedicine, and personalized care with a focus on accessibility and continuity.
Education & Training:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Internal medicine, preventative care, chronic disease management, and telehealth-based patient care.
Education:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Comprehensive family medicine, preventative care, and evidence-based treatment across the lifespan.
Education & Training:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Obesity medicine, metabolic health, weight management, and long-term wellness-focused care.
Board Certifications:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Internal medicine, telemedicine, and personalized care with a focus on accessibility and continuity.
Education & Training:
Providing patient care through Telezen MD’s physician-led telehealth platform.

Internal medicine, preventative care, chronic disease management, and telehealth-based patient care.
Education:
Providing patient care through Telezen MD’s physician-led telehealth platform.
Dosing, Safety, Medical Review, and What to Expect
PT-141, also known as bremelanotide, is a prescription peptide that works on specific pathways in the brain involved in sexual desire and arousal. Unlike medications that focus on blood flow or hormone levels, PT-141 acts on the central nervous system, which plays a major role in how desire is experienced.
Because desire is largely brain-driven, PT-141 is often explored when physical health appears normal but sexual interest or responsiveness feels diminished.
PT-141 may support sexual desire and arousal in people who feel mentally disconnected from desire or notice changes that don’t seem explained by hormones or circulation alone.
Many people consider PT-141 when desire feels muted, inconsistent, or harder to access, even when they otherwise feel healthy and stable.
Medications such as Viagra or Cialis primarily target blood flow and physical performance. PT-141 works differently by acting on brain pathways involved in desire and arousal.
For individuals whose concerns are more related to interest, motivation, or mental engagement rather than circulation alone, this distinction can matter.
PT-141 is available as both a nasal spray and a subcutaneous injection. The main difference between the two is how the medication is absorbed.
Injectable PT-141 is absorbed directly and can provide more consistent dosing for some people. Nasal spray PT-141 is absorbed through the nasal passages and can work very well for many individuals, especially those who prefer a non-injectable option.
Response varies. Some people do well with nasal spray, while others prefer injections for consistency.
Not necessarily. Many people respond well to PT-141 nasal spray and find it effective.
Injectable PT-141 is sometimes described as more predictable due to absorption, but that does not mean nasal spray is inferior. Effectiveness depends on the individual and how their body responds.
At Telezen MD, you select the option you’re interested in first. A licensed provider then reviews your intake to confirm that choice is appropriate and safe before prescribing.
PT-141 has been studied in clinical research for many years, including large human trials. It is not new or experimental and has an established research history in sexual health.
This long research background is often reassuring for people who want to understand what they’re taking.
When prescribed appropriately and used under medical supervision, PT-141 is generally well tolerated. As with any prescription medication, individual health factors and potential interactions matter.
This is why a medical intake and provider review are required before prescribing.
Some people may experience side effects such as nausea, flushing, or headache. Not everyone experiences side effects, and many find them mild or temporary.
Your provider reviews potential risks and considerations as part of your medical evaluation so you can make an informed decision.
Bremelanotide, the active compound in PT-141, has FDA approval for specific indications. Your provider can explain how this applies in a clinical context during review.
You select the PT-141 option you’re interested in and complete a medical intake. A licensed provider then reviews your health history, medications, and information to confirm whether PT-141 and the selected form are appropriate for you before prescribing.
Not every request is approved, and safety is always reviewed.
PT-141 is not intended for daily use unless specifically directed by a provider. Frequency depends on individual factors and provider guidance.
Instructions are included as part of your care.
Response timing varies. Some people notice effects within hours, while others may need more than one use to understand how their body responds.
Your provider can help set realistic expectations.
PT-141 may not be appropriate for individuals with certain medical conditions or medication interactions. This is determined during the medical intake and provider review.
PT-141 has been studied in both women and men. Suitability is determined based on individual health history rather than gender alone.
No treatment works the same way for everyone. Response can vary, and PT-141 may not be the right fit for every individual.
The next step is selecting the PT-141 option you’re interested in and completing the medical intake so a licensed provider can review your information.
Prescription PT-141 is available only following an online medical evaluation and prescription by a licensed healthcare provider, when deemed appropriate.
The information on this page is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual responses to treatment may vary.
Compounded medications are prescribed by licensed healthcare providers to meet specific patient needs. The FDA does not review or approve compounded medications for safety or effectiveness.
Actual product packaging may differ from images shown. If you experience any unexpected or concerning symptoms while using this treatment, contact your healthcare provider promptly.
The following peer-reviewed publications explore the development, biological mechanisms, and clinical research related to PT-141 (bremelanotide). These studies are provided for educational reference only and do not constitute medical claims or guarantees of outcomes.
1. New England Journal of Medicine
https://www.nejm.org/doi/full/10.1056/NEJMoa050758
Melanocortin receptor agonists and sexual function: Central mechanisms of action
2. Journal of Sexual Medicine
https://academic.oup.com/jsm/article/7/4pt1/1741/6844963
Bremelanotide: A melanocortin receptor agonist for the treatment of sexual dysfunction
3. Pharmacology & Therapeutics
https://www.sciencedirect.com/science/article/pii/S0163725811001786
Melanocortin receptors, behavior, and sexual motivation
4. FDA Center for Drug Evaluation and Research
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210557Orig1s000TOC.cfm
Bremelanotide FDA approval documentation and clinical trial review